Financial Planning & Information Services’s AbbVie ABBV Stock Holding History

Financial Planning & Information Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$360K	Buy	1,822 +4	+0.2%	+$747	0.05%	69
2024 Q2	$312K	Sell	1,818 -347	-16%	-$57.5K	0.05%	67
2024 Q1	$394K	Buy	2,165 +5	+0.2%	+$862	0.06%	65
2023 Q4	$335K	Buy	2,160 +5	+0.2%	+$729	0.05%	69
2023 Q3	$321K	Buy	2,155 +5	+0.2%	+$734	0.06%	70
2023 Q2	$290K	Buy	2,150 +5	+0.2%	+$733	0.05%	73
2023 Q1	$342K	Sell	2,145 -521	-20%	-$79.7K	0.07%	71
2022 Q4	$431K	Hold	2,666	–	–	0.09%	60
2022 Q3	$358K	Sell	2,666 -47	-2%	-$6.74K	0.09%	58
2022 Q2	$416K	Hold	2,713	–	–	0.1%	54
2022 Q1	$440K	Sell	2,713 -30	-1%	-$4.36K	0.1%	56
2021 Q4	$371K	Hold	2,743	–	–	0.09%	57
2021 Q3	$296K	Hold	2,743	–	–	0.08%	61
2021 Q2	$309K	Sell	2,743 -107	-4%	-$12.1K	0.09%	57
2021 Q1	$308K	Buy	2,850 +207	+8%	+$22.1K	0.09%	58
2020 Q4	$283K	Hold	2,643	–	–	0.1%	55
2020 Q3	$232K	Buy	+2,643	New	+$249K	0.09%	60

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Financial Planning & Information Services's ABBV Position: Q3 2024 in Review

Financial Planning & Information Services increased its AbbVie (ABBV) stake by 0.22% in Q3 2024, buying an estimated $747 and bringing the position to 1,822 shares worth $360K. The position accounts for 0.05% of the portfolio, ranked #69.

Financial Planning & Information Services first reported a position in ABBV in Q3 2020 and has held it in 17 quarters since. The position peaked at $440K in Q1 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Financial Planning & Information Services held 1,822 shares of AbbVie worth $360K as of Q3 2024.
Financial Planning & Information Services bought 4 AbbVie shares in Q3 2024, an estimated $747.
AbbVie made up 0.05% of Financial Planning & Information Services's portfolio in Q3 2024, its #69 holding.
Financial Planning & Information Services first reported a position in AbbVie in Q3 2020 and has held it in 17 quarters since.
Financial Planning & Information Services's AbbVie position peaked at $440K in Q1 2022.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Financial Planning & Information Services's 13F filing for Q3 2024, filed 12 Nov 2024.